# Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer

> **NCT06828263** · — · RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 130 (estimated)

## Conditions studied

- Prostate Cancer Metastatic Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06828263
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2043-06
- **Final completion:** 2043-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06828263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06828263, "Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06828263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*